[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AUPQ851000A0 - Rapid fatty acid delivery - Google Patents

Rapid fatty acid delivery

Info

Publication number
AUPQ851000A0
AUPQ851000A0 AUPQ8510A AUPQ851000A AUPQ851000A0 AU PQ851000 A0 AUPQ851000 A0 AU PQ851000A0 AU PQ8510 A AUPQ8510 A AU PQ8510A AU PQ851000 A AUPQ851000 A AU PQ851000A AU PQ851000 A0 AUPQ851000 A0 AU PQ851000A0
Authority
AU
Australia
Prior art keywords
fatty acid
acid delivery
rapid
rapid fatty
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ8510A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPQ8510A priority Critical patent/AUPQ851000A0/en
Publication of AUPQ851000A0 publication Critical patent/AUPQ851000A0/en
Priority to AU2001268819A priority patent/AU2001268819A1/en
Priority to PCT/AU2001/000766 priority patent/WO2002002102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPQ8510A 2000-06-30 2000-06-30 Rapid fatty acid delivery Abandoned AUPQ851000A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ8510A AUPQ851000A0 (en) 2000-06-30 2000-06-30 Rapid fatty acid delivery
AU2001268819A AU2001268819A1 (en) 2000-06-30 2001-06-29 Rapid fatty acid delivery
PCT/AU2001/000766 WO2002002102A1 (en) 2000-06-30 2001-06-29 Rapid fatty acid delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ8510A AUPQ851000A0 (en) 2000-06-30 2000-06-30 Rapid fatty acid delivery

Publications (1)

Publication Number Publication Date
AUPQ851000A0 true AUPQ851000A0 (en) 2000-07-27

Family

ID=3822577

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ8510A Abandoned AUPQ851000A0 (en) 2000-06-30 2000-06-30 Rapid fatty acid delivery

Country Status (2)

Country Link
AU (1) AUPQ851000A0 (en)
WO (1) WO2002002102A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252836B2 (en) 2003-01-13 2007-08-07 Penwest, Ltd. Food and feed compositions including resistant starch
ITMI20040187A1 (en) * 2004-02-06 2004-05-06 Cosmo Spa PHARMACEUTICAL OR DIETETIC COMPOSITIONS BASED ON SHORT CHAIN FATTY ACIDS AND COMPLEX SUGARS FOR INTESTINAL DYSFUNCTIONS
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
GB201213629D0 (en) 2012-07-31 2012-09-12 Imp Innovations Ltd Compounds and their effects on appetite control and insulin sensitivity
JP7136807B2 (en) 2017-04-17 2022-09-13 ザ・ユニバーシティ・オブ・シカゴ Polymeric materials for the intestinal delivery of short-chain fatty acids for therapeutic applications in human health and disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
CA2176719C (en) * 1993-11-17 2007-09-18 Geoffrey Anisson Fatty acid delivery system
AUPQ132599A0 (en) * 1999-07-01 1999-07-22 Commonwealth Scientific And Industrial Research Organisation Nasogastric enteral formulations

Also Published As

Publication number Publication date
WO2002002102A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU5139600A (en) Nutritional formulations
AU2002342968A1 (en) Fatty acid compounds, preparation and uses thereof
AU2000267458A1 (en) Hypercomputer
AU2001295657A1 (en) Formulation containing wax-esters
AU3843200A (en) Conjugated fatty acid esters
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002224884A1 (en) Substituted anthranilic acids
AU2001263839A1 (en) Liquid formulations
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2002214978A1 (en) Beta-Thio-amino acids
HU0104562D0 (en) Copolymer-based cosmetic compositions comprising an acid unit
AU1497802A (en) Ss-thio-amino acids
AU2001283344A1 (en) Dermatological formulation
AU2882601A (en) Connector
AU2002217245A1 (en) Rocker-connection connector
AUPQ851000A0 (en) Rapid fatty acid delivery
AU5474401A (en) Connector
AUPR099200A0 (en) New formulation
AU2001295815A1 (en) Multiple purpose catheter
AU2002229469A1 (en) Connector
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001268819A1 (en) Rapid fatty acid delivery
AU2001244628A1 (en) Pyroligneous acid
AU2001272099A1 (en) Acetylsalicylic acid solutions

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 6881901

Country of ref document: AU